Home > Insider Trading > Filing (0001529594-14-000006)

Filing Details

Accession Number:: 0001529594-14-000006
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2014-12-17 16:27:47
Reporting Period:: 2014-12-15

Filing Date:: 2014-12-17
Accepted Time:: 2014-12-17 16:27:47
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1459266	Zs Pharma Inc.	ZSPH	Pharmaceutical Preparations (2834)	263305698

Insiders

Cik	Name	Reported Address	Director	Officer	Large Shareholder	Other
1374953	P L Ii Fund Venture Rivervest	101 S. Hanley Road, Suite 1850 St Louis MO 63105	No	No	Yes	No
1435248	Jay Schmelter	101 S. Hanley Road, Suite 1850 C/O Rivervest Venture Partners St. Louis MO 63105	No	No	Yes	No
1529594	3X5 Special Opportunity Fund, L.p.	101 S. Hanley Road, Suite 1850 St. Louis MO 63105	No	No	Yes	No
1606398	Rivervest Venture Fund Ii (Ohio), L.p.	101 S. Hanley Road, Suite 1850 St. Louis MO 63105	No	No	Yes	No
1611642	Rivervest Venture Partners Ii, Llc	101 S. Hanley Road, Suite 1850 St. Louis MO 63105	No	No	Yes	No
1611643	Rivervest Venture Partners Ii, L.p.	101 S. Hanley Road, Suite 1850 St. Louis MO 63105	No	No	Yes	No
1611644	Rivervest Venture Partners Ii(Ohio), Llc	101 S. Hanley Road, Suite 1850 St. Louis MO 63105	No	No	Yes	No
1611646	Rivervest 3X5 Special Opportunity Managers, Llc	101 S. Hanley Road, Suite 1850 St. Louis MO 63105	No	No	Yes	No
1611648	3X5 Special Opportunity Partners, Llc	101 S. Hanley Road, Suite 1850 St. Louis MO 63105	No	No	Yes	No
1611651	C. Thomas Melzer	101 S. Hanley Road, Suite 1850 C/O Rivervest 3X5 Special Opportunity St. Louis MO 63105	No	No	Yes	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2014-12-15	365,354	$0.00	1,621,938	No	4	J	Direct
Common Stock	Disposition	2014-12-15	79,444	$47.09	123,247	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	J	Direct
No	4	S	Direct

Footnotes

Reflects a pro rata distribution by 3x5 Special Opportunity Fund, L.P. to its partners. As part of such distribution, an additional 6,489 was distributed by 3x5 Special Opportunity Fund, L.P. to its general partner, 3x5 Special Opportunity Partners, LLC. See footnote 3.
Consists of (a) 62,475 shares sold by RiverVest Venture Fund II, L.P. and (b) 16,969 shares sold by RiverVest Venture Fund II (Ohio), L.P. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $47.00 to $47.75, inclusive. The Reporting Person undertakes to provide to any security holder of ZS Pharma, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4.
John P. McKearn, Ph.D. is an authorized person and Thomas Melzer and Jay Schmelter are members of RiverVest 3x5 Special Opportunity Managers, LLC. RiverVest 3x5 Special Opportunity Managers, LLC is a member of 3x5 Special Opportunity Partners, LLC. 3x5 Special Opportunity Partners, LLC is the general partner of 3x5 Special Opportunity Fund, L.P. As an authorized person or member, as the case may be, of RiverVest 3x5 Special Opportunity Managers, LLC, Dr. McKearn, Messrs. Melzer and Schmelter may be deemed to share dispositive voting and investment power with respect to the shares held by such entities. Dr. McKearn, Messrs. Melzer and Schmelter each disclaim beneficial ownership of such shares except to the extent of his pecuniary interest therein.